BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 37673459)

  • 1. Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia.
    Sigvardsson M
    Genes Dev; 2023 Aug; 37(15-16):703-723. PubMed ID: 37673459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.
    Somasundaram R; Prasad MA; Ungerbäck J; Sigvardsson M
    Blood; 2015 Jul; 126(2):144-52. PubMed ID: 25990863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic gatekeeper function of B-lymphoid transcription factors.
    Chan LN; Chen Z; Braas D; Lee JW; Xiao G; Geng H; Cosgun KN; Hurtz C; Shojaee S; Cazzaniga V; Schjerven H; Ernst T; Hochhaus A; Kornblau SM; Konopleva M; Pufall MA; Cazzaniga G; Liu GJ; Milne TA; Koeffler HP; Ross TS; Sánchez-García I; Borkhardt A; Yamamoto KR; Dickins RA; Graeber TG; Müschen M
    Nature; 2017 Feb; 542(7642):479-483. PubMed ID: 28192788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
    Heltemes-Harris LM; Hubbard GK; LaRue RS; Munro SA; Yang R; Henzler CM; Starr TK; Sarver AL; Kornblau SM; Farrar MA
    Oncogene; 2021 Oct; 40(43):6166-6179. PubMed ID: 34535769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
    Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
    Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-lineage transcription factors and cooperating gene lesions required for leukemia development.
    Tijchon E; Havinga J; van Leeuwen FN; Scheijen B
    Leukemia; 2013 Mar; 27(3):541-52. PubMed ID: 23047478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
    Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
    Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
    Mullighan CG; Goorha S; Radtke I; Miller CB; Coustan-Smith E; Dalton JD; Girtman K; Mathew S; Ma J; Pounds SB; Su X; Pui CH; Relling MV; Evans WE; Shurtleff SA; Downing JR
    Nature; 2007 Apr; 446(7137):758-64. PubMed ID: 17344859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.
    Okuyama K; Strid T; Kuruvilla J; Somasundaram R; Cristobal S; Smith E; Prasad M; Fioretos T; Lilljebjörn H; Soneji S; Lang S; Ungerbäck J; Sigvardsson M
    PLoS Genet; 2019 Aug; 15(8):e1008280. PubMed ID: 31381561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early B-cell factor 1 regulates the expansion of B-cell progenitors in a dose-dependent manner.
    Åhsberg J; Ungerbäck J; Strid T; Welinder E; Stjernberg J; Larsson M; Qian H; Sigvardsson M
    J Biol Chem; 2013 Nov; 288(46):33449-61. PubMed ID: 24078629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
    Mehtonen J; Teppo S; Lahnalampi M; Kokko A; Kaukonen R; Oksa L; Bouvy-Liivrand M; Malyukova A; Mäkinen A; Laukkanen S; Mäkinen PI; Rounioja S; Ruusuvuori P; Sangfelt O; Lund R; Lönnberg T; Lohi O; Heinäniemi M
    Genome Med; 2020 Nov; 12(1):99. PubMed ID: 33218352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
    Souabni A; Jochum W; Busslinger M
    Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
    Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
    Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
    J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional damaging germline variants in ETV6, IKZF1, PAX5 and RUNX1 predisposing to B-cell precursor acute lymphoblastic leukemia.
    Wagener R; Elitzur S; Brozou T; Borkhardt A
    Eur J Med Genet; 2023 Apr; 66(4):104725. PubMed ID: 36764385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel PAX5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report.
    Barbosa TC; Lopes BA; Blunck CB; Mansur MB; Deyl AVS; Emerenciano M; Pombo-de-Oliveira MS
    BMC Med Genomics; 2018 Dec; 11(1):122. PubMed ID: 30563523
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Jia Z; Gu Z
    Front Oncol; 2022; 12():1023606. PubMed ID: 36387144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.
    Familiades J; Bousquet M; Lafage-Pochitaloff M; Béné MC; Beldjord K; De Vos J; Dastugue N; Coyaud E; Struski S; Quelen C; Prade-Houdellier N; Dobbelstein S; Cayuela JM; Soulier J; Grardel N; Preudhomme C; Cavé H; Blanchet O; Lhéritier V; Delannoy A; Chalandon Y; Ifrah N; Pigneux A; Brousset P; Macintyre EA; Huguet F; Dombret H; Broccardo C; Delabesse E
    Leukemia; 2009 Nov; 23(11):1989-98. PubMed ID: 19587702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
    Jardin F; Sahota SS
    Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.